CompletedNCT07093385
Intravitreal Faricimab in Patients With Refractory Macular Edema
PHASE2 · 43 planned enrolment
- Countries listed
- 1
- Registry update
- July 30, 2025
immortal.lifeTrial registrations containing the exact intervention label Faricimab Injection.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE2 · 43 planned enrolment
PHASE4 · 100 planned enrolment